Exchange listing
to be announced








What is MediLiVes

About MediLiVes

MediLiVes aims to disrupt the healthcare & telemedicine industry by lowering the cost & barrier
in conducting algorithmic medical examination models.

We built a platform for everyone.
To revolutionize telemedicine and healthcare Industry.

Telemedicine is a rapidly growing industry which has the potential to revolutionize the way we look at healthcare. The current market size of this industry stands at $10.3 billion and is expected to reach $49.1 billion by the year 2020.

MediLiVes is focused on telemedicine solutions. The MediLiVes platform enables healthcare professionals and patients to collect, store and harvest key findings from medical examinations data. The app is capable of recognizing more than 20 irregularities in ECG signals, making diagnosis significantly faster. There are more than 20 diagnostics which can be carried out using the MediLiVes devices.

What is MediLiVes?
How it works
MediLiVes Solutions

Problems & Solutions

It is possible to live longer and prevent ourselves from future civilization diseases, if we start today !
Join hands with MediLiVes. "Life it is. Live it."


A lot of lifestyle diseases have their roots due to the popularization of substances through popular culture. Through movies and mainstream media, people are exposed to alcohol consumption, smoking of cigarettes and drug use.

These diseases can be prevented by stopping the use of the substances or food that is causing the problem. Although in many cases, the disease is recognized much later in its development, which makes it significantly harder to cure. There is an absolute need to educate people, especially the younger population about the dangers of lifestyle diseases and their prevention.



MediLiVes brings technology called Analytical telemedicine system to make medical examinations cost effective and quick. MediLiVes is an innovative initiative offering unique, new-generation telemedicine solutions. Telemedicine, based on technology that enables a patient’s health condition to be monitored from a distance, is one of the fastest-growing industries in the world. The versatile nature of our core product means that it can find abnormalities not only in cardiology, but also in diabetes, dietetics, civilization diseases, and chronic illnesses.

Medical specialists are present across the globe – we aim to provide access to the best scientists, doctors, and healthcare providers to each and every human being.

MediLiVes Documents

Whitepaper, Terms & Conditions

MediLiVes is a well-planned and executed platform geared-up towards revolutionizing the way we look at healthcare today.
Let's learn more about this revolutionary project through it's whitepaper, tokensale terms & conditions and other policy documents.


Our white paper is an authoritative report and a guide that informs readers concisely about complex problems in our present healthcare system and presents the MediLiVes philosophy and solutions. We tried our best to help our readers understand the issues,and our approach to solve the problems, or to make a right decision.

The initial British term concerning a type of government-issued document has proliferated, taking a somewhat new meaning in business. In business, a white paper is closer to a form of marketing presentation, a tool meant to persuade customers and partners and promote a product or viewpoint, White papers may be considered grey literature.

Since MediLiVes is for our global community; the 'White Paper' or 'Whitepaper' can be downloaded here in English, Japanese, Russian and Chinese.

Tokensale Terms


MediLiVes Implementation Sheet

MediLiVes is not just another idea of introducing blockchain into health care
it is a revolution, which has power to change the way we look at healthcare today.

July 2017
Idea Generation and exploring possibilities of Medi Tech
April 2018
Meeting with doctors and construction of prototype
Nov 2018
Formation of Medi Science and birth of MediLiVes
Jan 2019
Technical and strategy deployment and implementation
May 2019
Private sales of tokens Live Now
June/July 2019
IEO Released on Latoken and other exchanges
August 2019
Partnership with Universities and other organisations
January 2020
Pilot Scheme deployed with various organisations
March 2020
International Roll out

Token Stats

If allowed to flourish, MediLiVes Blockchain Solution has the potential to benefit consumers and enterprise on the scale
[of] other transformative inventions like railroads, automobiles, telephones, computers, and the Internet itself.


Soft Cap: 1 Million USD

Hard Cap: 5 Million USD


MLIV tokens will be utilized to ensure frictionless transactions of tele-medicine globally. The tokenization of these payments, is a great leap forward for cryptocurrencies as a whole. MLIV tokens will only be available through a private sale and a public IEO on LaToken Exchange.

Token Name: MediLiVes Token

Symbol: MLIV

Total Tokens Minted: 2 Billion

Tokens for Sale 1.2 Billion (60%)

Initial Value: 1 MLIV = 0.03 USD

Token Type: ERC20

Min. Purchase: 0.25 ETH

Core Team

Creative Team

Creativity Requires The Courage To Let Go Of Certainty
You Can't Use Up Creativity; The More You Use, The More You Have.


Creative and
Dedicated People


Years of combined experience


Years of blockchain experience

Sunny Ahonsi
Chief Executive Officer & Chief Relationship Officer
Martin Territt
Chief Information Officer
John McKay
Chief Operating Officer
suzat fernandes
Suzat Fernandes
Chief Marketing Officer
Garry Singh
Garry Singh
Chief Marketing Strategist
Alex Wan
Alex Wan
Chief Communications Officer
Kyaw Zaw Htoo
Kyaw Zaw Htoo
Chief Business Development Officer
Grant Murrell
Grant Murrell
Chief Business Analyst
Caroline Garnham
Caroline Garnham
Chief Legal Officer
Project Team & Advisors

Project Team & Advisors of the platform

There are many ways to participate in MediLiVes project and we are here
to help new and motivated community members to give them a head start by becoming an Ambassador.

Jacinth Jeffers
Ambassador and Investor
Meena Bhandari
Ambassador and Investor
Sanna Soini
Sanna Soini
Ambassador and Investor
Anne Proton-McKay
Anne Proton-McKay
Training Manager
Dr. Azura Rozila
Dr. Azura Rozila
Ambassador and Investor
Dr. Landrith McLeod Isaac
Dr. Landrith McLeod Isaac
Dr. Bunmi Agboola
Dr. Bunmi Agboola
Medical Advisor
Dr. Tony Ogefere
Dr. Tony Ogefere
Medical Advisor
Nabila Bangura
Nabila Bangura
Senior Medical Practitioner
Tyrone Marcelle
Tyrone Marcelle
Ambassador and Investor
Marinka Natale
Marinka Natale
Shofique Miah
Shofique Miah
Marketing and Public Relations Officer
Des Amey
Desmond Amey
Financial Advisor
Richard Banji Owoyinka
Richard Banji Owoyinka
Ambassador and Investor

Frequently Asked & Answered Questions

We have tried to answer all frequently asked questions by our community members
still if we missed anything, please do not hesitate to get in touch.

We strongly recommend using a personal wallet for which you have full control like MEW (myetherwallet) etc. Refrain from keeping your cryptocurrency in a wallet provided to you by an exchange. It jeopardizes the security of your funds, as you are essentially not in control of that wallet.
As MediLiVes has choosen to begin an IEO (Initial Exchange Offering) instead of a regular ICO; MLIV will be listed on exchange(s) right from the begining of IEO process.
MediLiVes is an innovative telemedicine system that provides comprehensive health reports for patients, doctors, and paramedics. Our dedicated app lets users get detailed medical information and history at a glance.
As MLIV is an ERC20 token, it is compatible with any ERC20 wallet like MyEtherWallet. You do not need a special wallet to hold MLIV, your regular ETH wallet is good.
MediLiVes is here to solve several problems of the Medical/ Healthcare Industry. Primarily we want to speed up the medical examination process and get results shared with doctors within seconds. The AI-based system would not only read the reports but also predict your future health problems and prescribe more tests for a healthy and long life.
We are incredibly fortunate to have the support and expertise of medical experts and physicians that are renowned in the European Union and across the world.
An Initial Exchange Offering, as its name suggests, is conducted on the platform of a cryptocurrency exchange. Contrary to Initial Coin Offerings (ICOs), an IEO is administered by a crypto exchange on behalf of the startup that seeks to raise funds with its newly issued tokens.IEO participants do not send contributions to a smart contract, such as governs an ICO. Instead, they have to create an account on the exchange’s platform where the IEO is conducted. The contributors then fund their exchange wallets with coins and use those funds to buy the fundraising company’s tokens.
MLIV token is an ERC 20 token, the token name is 'MediLiVes Token'.
MLIV is available on Latoken during the IEO phase, post-IEO it will be listed on Latoken exchange. It will be listed on 4 other Tier 2 exchanges post IEO. Names of those exchanges will be revealed post-IEO.
During the IEO phase, 1 MLIV = 0.03 USD.

Recent Blogs Posts

MediLiVes aims to disrupt the healthcare & telemedicine industry
by lowering the cost & barrier in conducting algorithmic medical examination models.

Right here in a Blockchain conference in Hong Kong 4&5 May 2019

Another successful event, and even more recognition for the MediLives Project.

We built a platform for everyone. To revolutionize the telemedicine and healthcare Industry.

Telemedicine is a rapidly growing industry...

Sunny Ahonsi CEO of MediLiVes in Egypt May 2019, with the Young supporters of MediliVes’ project.

Sunny Ahonsi in Egypt May 2019, with parents and Young supporters of MediliVes’ project

Sunny Ahonsi , CEO of MediLiVes in Dubai April 2019 on the 4th gccfm Conference

Sunny Ahonsi as a guest speaker on the Economic, Social Political and Technological impact of the Blockchain of humanity

Sunny Ahonsi Ceo of MediLiVes on a Cruise with the names that count such as John McAfee

Sunny Ahons with John McAfee & The founding father and guru of the blockchain and crypto space; Charlie Lee, founder of litecoin….

Sunny Ahonsi The CEO of MediLiVes in a conference in London

How the use of technology can support to counter global terror threats, delegates include security experts from England, France, Nigeria, Cameroon…,

MediLiVes Focuses on Preventive Care

There is an old saying that “Prevention is better than cure”, MediLiVes will change our focus from disease management to counteractive action and wellbeing advancements.

Mr. Sunny Ahonsi, CEO MediLiVes meets Mr. Edwin Haynes, President at Haynes Global Services at a business meeting in London.

Edwin Haynes is an internationally respected and celebrated businessman from Houston, Texas.


Contact MediLiVes

Have questions? We’re happy to help.